Acasti Pharma Past Earnings Performance

Past criteria checks 0/6

Acasti Pharma has been growing earnings at an average annual rate of 4.7%, while the Pharmaceuticals industry saw earnings growing at 8.4% annually. Revenues have been growing at an average rate of 1% per year.

Key information

4.7%

Earnings growth rate

55.6%

EPS growth rate

Pharmaceuticals Industry Growth7.3%
Revenue growth rate1.0%
Return on equity-59.9%
Net Marginn/a
Last Earnings Update31 Dec 2023

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Acasti Pharma makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

DB:A1P0 Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 230-3985
30 Sep 230-4086
30 Jun 230-4288
31 Mar 230-42810
31 Dec 220-17511
30 Sep 220-17510
30 Jun 220-1168
31 Mar 220-1076
31 Dec 210-1294
30 Sep 210-1182
30 Jun 210-1873
31 Mar 210-2074
31 Dec 200386
30 Sep 200-699
30 Jun 200-211012
31 Mar 200-26816
31 Dec 190-56723
30 Sep 190-46626
30 Jun 190-42529
31 Mar 190-39429
31 Dec 180-31425
30 Sep 180-34322
30 Jun 180-20317
31 Mar 180-17312
31 Mar 170-825
30 Nov 160-725
31 Aug 160-726
31 May 160-626
29 Feb 160-525
30 Nov 150-507
31 Aug 150-117
31 May 150-328
28 Feb 150-137
30 Nov 140-255
31 Aug 140-875
31 May 141-874
28 Feb 140-1045
30 Nov 130-1064
31 Aug 131-854

Quality Earnings: A1P0 is currently unprofitable.

Growing Profit Margin: A1P0 is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: A1P0 is unprofitable, but has reduced losses over the past 5 years at a rate of 4.7% per year.

Accelerating Growth: Unable to compare A1P0's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: A1P0 is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (1.2%).


Return on Equity

High ROE: A1P0 has a negative Return on Equity (-59.95%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.